UK Health Radio Podcast
UK Health Radio Podcast
49: The Therapy Suite with Gavin J - Episode 49
49: The Therapy Suite with Gavin J - Episode 49
49: The Therapy Suite with Gavin J - Episode 49
Tuesday 2nd January 2024
Join Gavin J and Professor Saad Shakir on The Therapy Suite to explore drug safety, COVID-19 vaccines, and innovations in pharmacovigilance.
48 minutes
Informative
Empowering
Insightful
Compelling
Engaging
About this podcast
Overview:
Categories:
Mindfulness & Emotional Wellbeing
Spiritual & Personal Growth Journeys
Mindful Recovery
Entrepreneurship for Personal Growth
Navigating Intimate Relationships
Links:
Visit site
Episodes:
2846 (View all)
Do you want to link to this podcast?
Get the buttons here!Pharmacovigilance: Keeping Medicines and Vaccines Safe with Professor Saad Shakir
Episode Overview
- Explore the critical role of pharmacovigilance in safeguarding public health
- Understand the process of pharmacovigilance and its impact on healthcare
- Learn about the rigorous safety checks that drugs undergo during development
- Gain insights into emerging innovations in drug safety, including the use of artificial intelligence and genetics
- Discover the UK's leading role in observational studies and clinical trials
Pharmacovigilance is the branch of medicine which studies the safety of medicines in population so after medicines undergo the research and development and they go to authorization and licensing and they get authorized to be used by patients. Pharmacovigilance monitors the safety of these medicines on the people who receive the drugs after they are marketed, the impact on the health of people is very, very important because every medicine has its benefits and risks, has its benefits profile, and we study its evolving risk-benefit profile after it is marketed.
Ever wondered how medicines and vaccines stay safe even after they've hit the market? In this episode of The Therapy Suite on UK Health Radio Podcast, host Gavin J sits down with Professor Saad Shakir to demystify the world of pharmacovigilance, or drug safety. Professor Shakir, a leading expert in clinical pharmacology, shares his wealth of knowledge on how the safety of medicines is monitored and maintained long after they are approved for use.
The conversation dives into the nitty-gritty of pharmacovigilance, including how adverse reactions are identified and managed. You'll learn about the importance of evaluating the benefit-risk profile of medicines and the adjustments made to ensure their safe use. With the rapid development of COVID-19 vaccines fresh in everyone's minds, Professor Shakir sheds light on the extraordinary measures taken to ensure their safety. This episode also explores the rigorous safety checks that medicines undergo during development.
From clinical trials to observational studies, you'll get a behind-the-scenes look at the processes that keep us safe. The UK's unique position in the field, thanks to the NHS's comprehensive healthcare system, is also highlighted. But that's not all. The discussion takes an exciting turn as it delves into emerging innovations in pharmacovigilance. Discover how artificial intelligence, machine learning, and genetics are revolutionizing the way we monitor drug safety.
Professor Shakir explains how these technologies are being used to better predict and manage adverse reactions. Whether you're a healthcare professional, someone interested in medical safety, or just curious about how your medicines are kept safe, this episode offers a fascinating and informative listen. Tune in to gain a deeper understanding of the crucial role pharmacovigilance plays in safeguarding public health.